Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old

NCT07066540 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Viral Enteric Infection

Interventions

DRUG: Reamberin® solution for infusion, 1.5 %

Sponsor

POLYSAN Scientific & Technological Pharmaceutical Company